Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification-Reference-Cited by-同舟云学术

Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification

Published:2024-02-25 Issue:5 Volume:134 Page:756-763
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharma Tox

Author:

Baltzer Houlind Morten¹²³⁴^ORCID,Hansen Luise¹⁴,Iversen Esben¹^ORCID,Rasmussen Henrik Berg⁵,Larsen Jens Borggaard⁶,Jørgensen Steffen⁷^ORCID,Dalhoff Kim⁸⁹^ORCID,Damkier Per¹⁰¹¹^ORCID,Walls Anne B.³⁴,Vermehren Charlotte³⁴,Andersen Trine Rune Høgh¹²^ORCID,Kallemose Thomas¹,Christrup Lona⁴,Westergaard Niels¹³^ORCID

Affiliation:

1. Department of Clinical Research Copenhagen University Hospital Amager and Hvidovre Hvidovre Denmark

2. Emergency Department Copenhagen University Hospital Amager and Hvidovre Hvidovre Denmark

3. The Capital Region Pharmacy Herlev Denmark

4. Department of Drug Design and Pharmacology University of Copenhagen Copenhagen Denmark

5. Institute of Biological Psychiatry Mental Health Centre Sct. Hans Roskilde Denmark

6. The Danish Epilepsy Centre Filadelfia Dianalund Denmark

7. Centre for Engineering and Science University College Absalon Naestved Denmark

8. Department of Clinical Pharmacology Copenhagen University Hospital Bispebjerg and Frederiksberg Copenhagen Denmark

9. Department of Clinical Medicine University of Copenhagen Copenhagen Denmark

10. Department of Clinical Pharmacology Odense University Hospital Odense Denmark

11. Department of Clinical Research University of Southern Denmark Odense Denmark

12. Region Zealand Hospital Pharmacy Roskilde Denmark

13. Centre for Nursing University College Absalon Roskilde Denmark

Funder

Novo Nordisk Fonden

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcpt.13990

Reference22 articles.

1. Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation

2. Drug metabolism and drug transport of the 100 most prescribed oral drugs

3. Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects

4. Introducing pharmacogenetic testing with clinical decision support into primary care: a feasibility study

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a quick guide for assessment of the most frequently used renal risk medication in Danish hospitals and primary care;Basic & Clinical Pharmacology & Toxicology;2024-08-20